The effect of N-acetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis

Critical Care Medicine

Volumn 31, Issue 11, 2003, Pages 2574-2578

  Paterson, Ross L ^a   Galley, Helen F ^a   Webster, Nigel R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Antioxidant; Glutathione; Intercellular adhesion molecule 1; Interleukin 6; Interleukin 8; N acetylcysteine; Nuclear factor B; Sepsis; Transcription factor

Indexed keywords

ACETYLCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INFUSION; ENZYME IMMUNOASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; INTENSIVE CARE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SEPSIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACETYLCYSTEINE; ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; INFUSIONS, INTRAVENOUS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; NF-KAPPA B; SEPSIS;

EID: 0344676399     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000089945.69588.18     Document Type: Article

References (40)

1. Blackwell TS, Christman JW: The role of nuclear factor κB in cytokine gene regulation. Am J Respir Cell Mol Biol 1997; 17:3-9
2. Sun Y, Oberley LW: Redox regulation of transcriptional activators. Free Radic Biol Med 1996; 21:335-348
3. Janssen-Heininger YMW, Poynter ME, Baeuerle PA: Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic Biol Med 2000; 28:1317-1327
4. Jersmann HP, Hii CS, Ferrante JV, et al: Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways. Infect Immun 2001; 69: 1273-1279
5. Libermann TA, Baltimore D: Activation of interleukin-6 expression through the NF-kappa B transcription factor. Mol Cell Biol 1990; 10:2327-2334
6. Kunsch C, Rosen CA: NF-kappa B subunit specific regulation of the interleukin-8 promoter. Mol Cell Biol 1993; 13:6137-6146
7. Kunsch C, Lang RK, Rosen CA, et al: Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. J Immunol 1994; 153:153-164
8. Bohrer H, Qiu F, Zimmermann T, et al: Role of NFκB in the mortality of sepsis. J Clin Invest 1997; 100:972-985
9. Arnalich F, Garcia-Palomero E, Lopez J, et al: Predictive value of nuclear factor kappa B activity and plasma cytokine levels in patients with sepsis. Infect Immun 2000; 68: 1942-1945
10. Paterson RL, Galley HF, Dhillon JK, et al: Increased nuclear factor kappa B activation in critically ill patients who die. Crit Care Med 2000; 28:1047-1051
11. Adib-Conquy M, Adrie C, Moine P, et al: NF-kappa B expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med 2000; 162:1877-1883
12. Moldeus P, Cotgreave IA, Berggren M: Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration 1986; 50: 31-42
13. Rahman I, MacNee W: Regulation of redox glutathione levels and gene transcription in lung inflammation: Therapeutic approaches. Free Radic Biol Med 2000; 28:1405-1420
14. Fox ES, Brower SJ, Bellezzo JM, et al: N-Acetylcysteine and α-tocopherol reverse the inflammatory response in activated rat Kupffer cells. J Immunol 1997; 158: 5418-5423
15. Yamashita N, Koizumi H, Murata M, et al: Nuclear factor kappa B mediates interleukin-8 production in eosinophils. Int Arch Allergy Immunol 1999; 120:230-236
16. G-monomethylarginine, on accumulation of interleukin-6 and interleukin-8, and nuclear factor-kappaB activity in a human endothelial cell line. Crit Care Med 1999; 27:908-912
17. Blackwell TS, Blackwell TR, Holden EP, et al: In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 1996; 157:1630-1637
18. Kheir-Eldin AA, Motawi TK, Gad MZ, et al: Protective effect of vitamin E, β-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. Int J Biochem Cell Biol 2001; 33:475-482
19. Cuzzocrea S, Mazzon E, Dugo L, et al: Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat. FASEB J 2001; 15:1187-1200
20. Villa P, Ghezzi P: Effect of N-acetyl-L-cysteine on sepsis in mice. Eur J Pharmacol 1995; 292:341-344
21. Zhang H, Spapen H, Nguyen DN: Protective effects of N-acetyl-L-cysteine in endotoxemia. Am J Physiol 1994; 266:H1746-H1754
22. Harrison P, Keays R, Bray G, et al: Improved outcome in paracetamol-induced fulminant hepatic failure following late administration of N-acetylcysteine. Lancet 1990; 335: 1572-1573
23. Keays R, Harrison PM, Wendon JA, et al: Intravenous N-acetylcysteine in paracetamol-induced fulminant hepatic failure: A prospective controlled trial. BMJ 1991; 303: 1026-1029
24. Suter PM, Domenghetti G, Schaller MD, et al: N-acetylcysteine enhances recovery from acute lung injury in man: A randomised, double-blind, placebo-controlled clinical study. Chest 1994; 105:190-194
25. Spies CD, Reinhart K, Witt I, et al: Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double-blind study. Crit Care Med 1994; 22: 1738-1746
26. Spapen H, Zhang H, Demanet C, et al: Does N-acetyl-L-cysteine influence cytokine responses during early human septic shock? Chest 1998; 113:1616-1624
27. Bone RC, Balk RA, Cerra FB: ACCP/SCCM consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-1655
28. Vincent JL, Moreno R, Takala J, et al: The SOFA score to describe organ dysfunction/ failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
29. Goode HF, Webster NR, Howdle PD, et al: Nitric oxide production by human peripheral blood polymorphonuclear leukocytes. Clin Sci 1994; 86:411-415
30. Essani NA, Fisher MA, Jaeschke H: Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with suppression of TNF-alpha formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock 1997; 7:90-96
31. Chang CK, Llanes S, Schumer W: Inhibitory effect of dimethylsulphoxide on nuclear factor κB activation and intracellular adhesion molecules-1 gene expression in septic rats. J Surg Res 1999; 82:294-299
32. Dofferhoff AS, Bom VJ, de Vries-Hospers HG, et al: Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor and acute phase proteins during treatment of severe sepsis in humans. Crit Care Med 1992; 20:185-192
33. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119:771-778
34. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103:565-567
35. Cowley HC, Heney D, Gearing AJ, et al: Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study. Crit Care Med 1994; 22:651-657
36. Shames BD, Selzman CH, Meldrum DR, et al: Interleukin-10 stabilizes inhibitory kappa B-alpha in human monocytes. Shock 1998; 10: 389-394
37. Lentsch AB, Shanley TP, Sarma V, et al: In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest 1997; 100: 2443-2448
38. Goode HF, Cowley HC, Walker BE, et al: Decreased antioxidant status and increased lipid peroxidation in patients with sepsis and secondary organ dysfunction. Crit Care Med 1995; 23:646-651
39. Galley HF, Davies MJ, Webster NR: Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 1996; 24:1649-1653
40. Cowley HC, Bacon PJ, Goode HF, et al: Plasma antioxidant potential in severe sepsis: A comparison of survivors and non-survivors. Crit Care Med 1996; 24:1179-1183